The beginning of the end of hepatitis C?
Hepatitis C treatment gap in Europe: France doing well but Italy treated fewer than one in a hundred patients in 2010
Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common
Movement for global access to hepatitis C treatment building momentum
Report highlights major failings in UK response to hepatitis C
Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis
French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection
Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients
